IN192749B - - Google Patents
Info
- Publication number
- IN192749B IN192749B IN1155DE2002A IN192749B IN 192749 B IN192749 B IN 192749B IN 1155DE2002 A IN1155DE2002 A IN 1155DE2002A IN 192749 B IN192749 B IN 192749B
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1155DE2002 IN192749B (de) | 2002-11-15 | 2002-11-15 | |
| AU2003276549A AU2003276549A1 (en) | 2002-11-15 | 2003-11-13 | Pharmaceutical compositions containing a biguanide-glitazone combination |
| CNA2003801070711A CN1728996A (zh) | 2002-11-15 | 2003-11-13 | 含双胍－格列酮组合的药物组合物 |
| PCT/IB2003/005140 WO2004045608A1 (en) | 2002-11-15 | 2003-11-13 | Pharmaceutical compositions containing a biguanide-glitazone combination |
| US10/534,909 US20060141023A1 (en) | 2002-11-15 | 2003-11-13 | Pharmaceutical compositions containing abiguanide-glitazone combination |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1155DE2002 IN192749B (de) | 2002-11-15 | 2002-11-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN192749B true IN192749B (de) | 2004-05-15 |
Family
ID=32321379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1155DE2002 IN192749B (de) | 2002-11-15 | 2002-11-15 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060141023A1 (de) |
| CN (1) | CN1728996A (de) |
| AU (1) | AU2003276549A1 (de) |
| IN (1) | IN192749B (de) |
| WO (1) | WO2004045608A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US7785627B2 (en) * | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| KR101114808B1 (ko) | 2003-01-29 | 2012-02-15 | 다케다 야쿠힌 고교 가부시키가이샤 | 피복 제제의 제조법 |
| MXPA05014092A (es) * | 2005-12-20 | 2007-06-20 | Leopoldo De Jesus Espinosa Abdala | Composiciones farmaceuticas que comprenden sustancias derivadas de la tiazolidinedionas combinadas con una biguanida para su uso en diabetes mellitus tipo 2. |
| CL2007001194A1 (es) * | 2006-04-27 | 2008-01-04 | Takeda Pharmaceutical | Preparacion farmaceutica solida que comprende particulas que comprenden (i) particulas de nucleo con excipiente y (ii) pioglitazona o una sal de la misma y un polimero soluble en acido, como copolimero de aminoalquil metacrilato e o dietilaminoacetato de polivinilacetal, ambos recubriendo el nucleo |
| DE602008003522D1 (de) | 2007-02-01 | 2010-12-30 | Takeda Pharmaceutical | Feste zubereitung mit alogliptin und pioglitazon |
| JP2010521492A (ja) * | 2007-03-15 | 2010-06-24 | ネクティド，インク． | 徐放性ビグアニド組成物、および即時性ジペプチジルペプチダーゼｉｖ阻害剤組成物を含む抗糖尿病合剤 |
| US8551524B2 (en) | 2008-03-14 | 2013-10-08 | Iycus, Llc | Anti-diabetic combinations |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| PE20130227A1 (es) | 2010-05-11 | 2013-02-27 | Janssen Pharmaceutica Nv | Formulaciones farmaceuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienilmetilbenceno como inhibidores de sglt |
| JP6093699B2 (ja) * | 2010-07-06 | 2017-03-08 | ヤンセン ファーマシューティカ エヌ．ベー． | 糖尿病のコ−セラピー治療のための製剤 |
| US20120093878A1 (en) * | 2010-07-30 | 2012-04-19 | Ranbaxy Laboratories Limited | Pharmaceutical compositions containing a biguanide and a thiazolidinedione |
| US20130251795A1 (en) * | 2010-07-30 | 2013-09-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions containing a biguanide and a low dose antidiabetic agent |
| JP2013538807A (ja) * | 2010-09-01 | 2013-10-17 | ルピン・リミテッド | メトホルミンおよびピオグリタゾンを含む医薬組成物 |
| AU2012241897C1 (en) | 2011-04-13 | 2017-05-11 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of SGLT2 |
| EA201490840A1 (ru) | 2011-10-21 | 2014-08-29 | Такеда Фармасьютикал Компани Лимитед | Препарат с замедленным высвобождением |
| EP2638898A1 (de) * | 2012-03-16 | 2013-09-18 | Sanovel Ilac Sanayi ve Ticaret A.S. | Metformin- und Pioglitazonformulierung mit verschiedenen Freisetzungsprofilen |
| EP2987489A4 (de) * | 2013-04-19 | 2016-09-07 | Takeda Pharmaceutical | Arzneimittelformulierung mit verzögerter freisetzung |
| CN103432128B (zh) * | 2013-08-26 | 2015-11-18 | 中国人民解放军第150中心医院 | 一种盐酸吡格列酮缓释微丸制剂含药层的组配方法 |
| CN103432129B (zh) * | 2013-08-26 | 2016-01-27 | 中国人民解放军第150中心医院 | 一种盐酸吡格列酮缓释微丸制剂的组配方法 |
| CN103432131A (zh) * | 2013-09-11 | 2013-12-11 | 中国药科大学 | 一种含有盐酸吡格列酮和盐酸二甲双胍的复方制剂及其制备方法 |
| CN104473894A (zh) * | 2014-12-18 | 2015-04-01 | 浙江华海药业股份有限公司 | 一种盐酸吡格列酮载药包衣制剂及其制备方法 |
| CN105749233A (zh) * | 2016-04-11 | 2016-07-13 | 温玉平 | 一种治疗糖尿病的中药组方 |
| CN109330995B (zh) * | 2018-12-05 | 2021-05-18 | 河北医科大学 | 一种包载短效降糖药的微丸及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| DE60129425T2 (de) * | 2000-05-01 | 2008-04-17 | Aeropharm Technology LLC, Dover | Kernformulierung |
| US6780432B1 (en) * | 2000-05-01 | 2004-08-24 | Aeropharm Technology, Inc. | Core formulation |
| US6451342B2 (en) * | 2000-05-01 | 2002-09-17 | Aeropharm Technology Incorporated | Core formulation comprised of troglitazone and a biguanide |
| US6524621B2 (en) * | 2000-05-01 | 2003-02-25 | Aeropharm Technology Inc. | Core formulation |
| US6461639B2 (en) * | 2000-05-01 | 2002-10-08 | Aeropharm Technology, Inc. | Core formulation |
| US6296874B1 (en) * | 2000-05-01 | 2001-10-02 | Aeropharm Technology Incorporated | Core formulation comprising troglitazone and abiguanide |
| US20030187074A1 (en) * | 2002-03-04 | 2003-10-02 | Javed Hussain | Oral compositions for treatment of diabetes |
-
2002
- 2002-11-15 IN IN1155DE2002 patent/IN192749B/en unknown
-
2003
- 2003-11-13 WO PCT/IB2003/005140 patent/WO2004045608A1/en not_active Application Discontinuation
- 2003-11-13 US US10/534,909 patent/US20060141023A1/en not_active Abandoned
- 2003-11-13 AU AU2003276549A patent/AU2003276549A1/en not_active Abandoned
- 2003-11-13 CN CNA2003801070711A patent/CN1728996A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1728996A (zh) | 2006-02-01 |
| WO2004045608A9 (en) | 2004-08-26 |
| AU2003276549A8 (en) | 2004-06-15 |
| WO2004045608A1 (en) | 2004-06-03 |
| AU2003276549A1 (en) | 2004-06-15 |
| US20060141023A1 (en) | 2006-06-29 |